These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Learning difficulties of Indonesian children treated with pyrithioxine. Setyonegoro RK; Budiman M; Hardjawana B; Sobari T; Dhoemandi E Mod Med Asia; 1978 Jun; 14(6):39-42. PubMed ID: 661806 [No Abstract] [Full Text] [Related]
46. Effects of penicillamine on the kidney and on taste. Jaffe IA Postgrad Med J; 1968 Oct; ():Suppl:15-8. PubMed ID: 5706604 [No Abstract] [Full Text] [Related]
47. [The basic treatment of rheumatoid arthritis. Current trends]. Suţeanu S; Manuchian M Med Interne; 1984; 22(4):241-51. PubMed ID: 6393302 [No Abstract] [Full Text] [Related]
48. Bucillamine (a new therapeutic agent for rheumatoid arthritis) induced nephrotic syndrome: a report of two cases and review of the literature. Isozaki T; Kimura M; Ikegaya N; Arai T; Fujigaki Y; Hishida A; Kaneko E Clin Investig; 1992 Nov; 70(11):1036-42. PubMed ID: 1472834 [TBL] [Abstract][Full Text] [Related]
49. [Heparin treatment of rheumatoid arthritis and systemic lupus erythematosus]. Murav'ev IuV; Samoĭlova SI Ter Arkh; 1979; 51(7):48-52. PubMed ID: 494087 [No Abstract] [Full Text] [Related]
50. Nephrotic syndrome induced by tolmetin. Chatterjee GP JAMA; 1981 Oct; 246(14):1589. PubMed ID: 7277633 [No Abstract] [Full Text] [Related]
51. Development of Nephrotic Syndrome in a Patient with Rheumatoid Arthritis Treated with Certolizumab. Butendieck RR; Bhattacharya T; Geiger X J Rheumatol; 2016 Sep; 43(9):1770-2. PubMed ID: 27587019 [No Abstract] [Full Text] [Related]
52. Clinical efficacy and adverse effects of tiopronin in rheumatoid arthritis. Report of a follow-up in 50 patients. Ambanelli U; Manganelli P; Ferraccioli GF Z Rheumatol; 1982; 41(5):235-9. PubMed ID: 7158085 [TBL] [Abstract][Full Text] [Related]
53. [Prolonged gold therapy for nephrotic syndrome in a patient with undiagnosed polyarthritis]. Leszczyński P; Mackiewicz SH Pol Arch Med Wewn; 1996 Aug; 96(2):153-6. PubMed ID: 9122003 [TBL] [Abstract][Full Text] [Related]
54. [Pyrithioxin (Encephabol) in the treatment of patients with organic psychosyndrom in involution. Clinical, EEG and experimental psychological study (author's transl)]. Misurec J; Sláma B; Náhunek K Cesk Psychiatr; 1976 Feb; 72(1):14-23. PubMed ID: 773551 [No Abstract] [Full Text] [Related]
55. [Drug-induced pemphigus]. Tholen S Z Hautkr; 1986 May; 61(10):719-23. PubMed ID: 3521113 [TBL] [Abstract][Full Text] [Related]
57. Clinical effect of Encephabol (pyritinol) in the treatment of cerebrovascular disorders. Tazaki Y; Omae T; Kuromaru S; Ohtomo E; Hasegawa K; Mori A; Kurihara M; Kutsusawa N; Okada T J Int Med Res; 1980; 8(2):118-26. PubMed ID: 6989681 [TBL] [Abstract][Full Text] [Related]
58. [Nephrotic syndrome and amyloidosis in chronic rheumatic processes]. Schilling A Med Klin; 1969 Mar; 64(10):425-9. PubMed ID: 5771968 [No Abstract] [Full Text] [Related]
59. The nephrotic syndrome as a complication of gold therapy. Vaamonde CA; Hunt FR Arthritis Rheum; 1970; 13(6):826-34. PubMed ID: 5495393 [No Abstract] [Full Text] [Related]